← Leaderboards
Yury Polikanov
University Of Illinois At Chicago
$4,048,503
Attributed
$6,885,286
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,885,286 · 8
By mechanism
R01$4,233,384 · 3
R21$1,102,844 · 3
R35$819,031 · 1
R56$730,027 · 1
Top collaborators
- Alexander S Mankin7 shared
- Terry William Moore5 shared
- Nora Vazquez-Laslop5 shared
- Zackery P. Bulman1 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Miljan Simonovic$2,658,194
- Alexander S Mankin$8,923,069
- Nora Vazquez-Laslop$3,270,867
- Zackery P. Bulman$2,580,287
Others in their field
Other Emerging Leaders on “Structure”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,827,589
- John Damon Chodera · Sloan-Kettering Inst Can Research$62,074,236
Research focus
StructureComplexRibosomesAntibioticsPharmaceutical PreparationsProtein BiosynthesisBindingPeptidesTranslationsGrowthAnti-Bacterial AgentsClinically RelevantCellsMolecularCrystallizationProteinsBacteriaProtein Synthesis InhibitorsTransfer RnaPropertyInsightSiteSpecificityAffect
Grant awards (18)
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action$698,327
R01 · FY2025 · AI
Structural basis for ribosome function and inhibition in bacteria.$392,351
R35 · FY2025 · GM · contact PI
Structural, functional, and microbiological exploration toward synergistic dual aminoglycoside combinations$237,518
R21 · FY2025 · AI
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action$698,327
R01 · FY2024 · AI
Structural basis for ribosome function and inhibition in bacteria.$426,680
R35 · FY2024 · GM · contact PI
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action$749,951
R01 · FY2023 · AI
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action$454,250
R01 · FY2022 · AI
Molecular mechanisms of action of ribosome-targeting antibiotics.$314,531
R01 · FY2022 · GM · contact PI
Structural basis of Cfr-mediated resistance to antibiotics targeting the bacterial ribosome$192,813
R21 · FY2022 · AI · contact PI
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action$730,027
R56 · FY2021 · AI
Molecular mechanisms of action of ribosome-targeting antibiotics.$314,531
R01 · FY2021 · GM · contact PI
Studies on the mechanisms governing selenium incorporation into proteins$311,805
R01 · FY2021 · GM · contact PI
Structural basis of Cfr-mediated resistance to antibiotics targeting the bacterial ribosome$232,788
R21 · FY2021 · AI · contact PI
Molecular mechanisms of action of ribosome-targeting antibiotics.$62,600
R01 · FY2021 · GM · contact PI
Molecular mechanisms of action of ribosome-targeting antibiotics.$314,531
R01 · FY2020 · GM · contact PI
Molecular mechanisms of action of ribosome-targeting antibiotics.$314,531
R01 · FY2019 · GM · contact PI
Structural basis of Erm-mediated macrolide resistance$199,875
R21 · FY2019 · AI
Structural basis of Erm-mediated macrolide resistance$239,850
R21 · FY2018 · AI